NotíciasÚltima atualização: Terça-feira, 04 de Junho de 2024
Cui Min et al. | Lipids in Health and Disease 2024; 23(1):...
Iron is involved in the formation of hemoglobin and many other functions. However, excessive intake of...
Nailin Li | Journal of Internal Medicine 2024; AOP:...
Platelet hyperactivity/thrombosis and hyperlipidaemia are the two leading risk factors for atherosclerosis...
Caroline R. Hill et al. | Molecular Nutrition & Food Research...
Metabolic syndrome is a multifactorial condition featuring abdominal obesity, insulin resistance, hyperglycemia,...
Shah, Nimish N.Md et al. | Circulation: Cardiovascular Quality...
* For patients with very-high-risk atherosclerotic cardiovascular disease, professional society guidelines...
Yu Deng et al. | Skin Research and Technology 2024; 30(5):...
Dyslipidemia, characterized by abnormal lipid levels in the bloodstream, is commonly associated with...
Chia‐Pin
Lin
MD
et al. | Journal of the American Heart Association...
In patients with concomitant hypertension and hypercholesterolemia, a fixed‐dose combination of...
van den Bosch, Sibbeliene E. et al. | Current Opinion in Lipidology 2024;...
Familial hypercholesterolemia is the most common metabolic disease caused by a genetic variation in one...
Allison DunnPharmD et al. | Journal of clinical pharmacology 2024;...
Cardiovascular disease (CVD) has remained the leading world‐wide cause of morbidity and mortality...
Serrano-Morales José-Manuel et al. | Journal of Ophthalmology 2024 (2024),...
Dyslipidemia is a metabolic disorder characterized by abnormal levels of serum lipids, such as cholesterol...
Lin Chenquan et al. | npj Schizophrenia 2024; 10(1): 52
Schizophrenia as a complicated and severe mental disease, influences about 1% of the population around...
Hiroki
Ono
et al. | Journal of Gastroenterology and Hepatology...
Metabolic dysfunction‐associated steatotic liver disease (MASLD), formerly called non‐alcoholic...
Sophie Béliard
et al. | Diabetologia 2024; 67(6): 974-84
There is a high burden of atherosclerotic CVD (ASCVD) risk in people with diabetes. The primary target...
Yao Lei et al. | Journal of Orthopaedic Surgery and Research...
Rotator cuff tears (RCTs) are common conditions in old individuals who can result in persistent pain...
Reijnders Esther et al. | Clinical proteomics 2024; 21(1): 19
Cardiovascular disease (CVD) is a leading cause of death worldwide and is associated with significant...
Baluku Joseph Baruch et al. | Lipids in Health and Disease 2024; 23(1):...
Tuberculosis (TB) remains the leading infectious cause of mortality globally [1]. Moreover, individuals...
Pesquisa bibliográficaAlvo e aperfeiçoe sua pesquisa de informações médicas
Pesquisa por revista
1042 artigos disponíveis
Pesquisa por assunto
Top artigosOs 5 artigos mais lidos pelos leitores
Nailin Li | Journal of Internal Medicine 2024; AOP:...
Platelet hyperactivity/thrombosis and hyperlipidaemia are the two leading risk factors for atherosclerosis [1–6]. Hyperlipidaemia is the classical cause of atherosclerosis; high levels of low‐density...
Cui Min et al. | Lipids in Health and Disease 2024; 23(1):...
Iron is involved in the formation of hemoglobin and many other functions. However, excessive intake of iron may pose some health risks. Free iron can destroy cellular macromolecules through the Fenton...
Caroline R. Hill et al. | Molecular Nutrition & Food Research...
Metabolic syndrome is a multifactorial condition featuring abdominal obesity, insulin resistance, hyperglycemia, atherogenic dyslipidemia, and hypertension. Its clustering of symptoms acts as an antecedent...
04 - Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies?
Sophie Béliard
et al. | Diabetologia 2024; 67(6): 974-84
There is a high burden of atherosclerotic CVD (ASCVD) risk in people with diabetes. The primary target to reduce this risk is lowering LDL-cholesterol (LDL-C), with statins the cornerstone of ASCVD prevention...
Hiroki
Ono
et al. | Journal of Gastroenterology and Hepatology...
Metabolic dysfunction‐associated steatotic liver disease (MASLD), formerly called non‐alcoholic fatty liver disease (NAFLD), is the most common chronic liver disease, with a morbidity rate...